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INTRoduCTIoN
Currently radiological techniques are the procedures 
of choice in the identification of malformative, inf-
lammatory and neoplastic diseases1-3; histopatholo-
gical analyses confirm the radiological diagnosis4,5.
Multidetector-row Computed Tomography (MDCT) is 
aBSTracT
The aim of this study is to quantitatively assess radiation com-
ma, and pancreatic enhancement by split-bolus intravenous in-
jection of contrast material using 64-slice CT. Single-pass split-
bolus MDCT of the chest and abdomen was performed in 37 
patients (female: 18, male: 9; mean age, 66.1±14.2 years; range 
17-80 years) without pancreatic disease. Regions of interest in 
the pancreatic head, body and tail were drawn, and mean at-
tenuation values for pancreatic parenchymal phase (PPP) of the 
standard MDCT protocol and split-bolus were calculated. P<0.05 
was considered statistically significant. Mean effective dose by 
split-bolus was measured. In all MDCT examinations split-bolus 
protocol allowed acquisition of optimal images. Mean pancreatic 
enhancement was higher by split-bolus with respect to PPP of 
standard triphasic MDCT (131.35 HU±20.63 vs 126.1 HU±20.01). 
Reduction of dose using MDCT split-bolus was approximately 
17%. In conclusion MDCT split-bolus protocol provides an optimal 
pancreatic enhancement, significantly greater than the enhance-
ment of standard MDCT on PPP which confers an advantage for 
the detection and staging of pancreatic tumors.
Keywords: Pancreas, multidetector-row computed tomog-
raphy, radiation dose, oncology
Öz
Bu çalışmanın amacı, bölünmüş-bolus intravenöz kontrast mad-
de kullanılarak yapılan 64 kesitli BT ile pankreatik artışı ve rad-
yasyon dozunu kantitatif olarak değerlendirmektir. Pankreatik 
bir hastalığı olmayan 37 hastaya (kadın: 18, erkek: 9, ortalama 
yaş: 66,1±14,2 yaş, aralık 17-80 yaş) göğüs ve abdomen tek geçiş 
bölünmüş-bolus MDBT uygulandı. Pankreas başı, gövdesi ve kuy-
ruğundaki ilgili bölgeler değerlendirildi ve standart MDBT proto-
kolünün pankreatik parankimal faz (PPF) için ortalama zayıflama 
değerleri ve bölünmüş-bolus dozları ölçüldü. P<0.05 değeri ista-
tistiksel olarak anlamlı kabul edildi. Bölünmüş-bolus uygulama-
sının ortalama efektif dozu ölçüldü. Tüm MDBT incelemelerinde 
bölünmüş-bolus protokolü kaliteli görüntülere izin verdi. Ortala-
ma panreatik artış PPF için bölünmüş-bolus uygulamasında stan-
dart trifazik MDBT e göre daha yüksekti (131,35 HU±20,63 vs 
126.1 HU±20.01). bölünmüş bolus dozlu MDBT ‘de dozda azalma 
yaklaşık olarak %17 idi. Sonuç olarak, bölünmüş-bolus protokol-
lü MDBT optimal pankreatik artış sağlar, pankreatik parankimal 
faz için özellikle standart MDBT değerlendirmesine göre önemli 
ölçüde üstünlük sağlar ve pankreas tümörlerinin belirlenmesi ve 
evrelemesi için avantajlıdır.
Anahtar kelimeler: Pankreas, multidetektör-dizi bilgisayarlı to-
mografi, radyasyon dozu, onkoloji
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the most widely used method for the evaluation of 
pancreatic and non-pancreatic neoplastic diseases6-8. 
In this setting the knowledge of magnitude and con-
sistency of the normal pancreatic enhancement and 
of optimal contrast differences between pancreas 
tumor and pancreas parenchyma is essential to en-
sure detection of lesions and accurate evaluation of 
peripancreatic vessels or lymph nodes9,10. 
 
In the literature a multitude of CT protocols for the 
assessment of pancreatic enhancement and staging 
of pancreatic tumors has been reported. Standard CT 
protocols involve bi- or triphasic techniques with dif-
ferent results; one of the most relevant limitation of 
multiphasic CT technique is the patient’s exposure to 
increased radiation doses11-24. 
Recently, instead of standard pancreatic multiphase 
or pancreatic CT, split-bolus MDCT (SB-MDCT) tech-
nique for detection, staging and follow-up of panc-
reatic tumors has been proposed25. SB-MDCT, com-
bining arterial phase (AP) and portal venous phase 
(PVP), allows a better tumor conspicuity reducing 
radiation dose.
At our institution, we implemented the SB-MDCT 
protocol for oncologic patients that combines AP and 
PVP in a single-pass enabling, in addition to images 
of diagnostic quality, a relevant reduction in radiati-
on exposure and in the number of images to be read 
and stored26.
Our aim was to quantitatively assess pancreatic en-
hancement by split-bolus intravenous injection of 
contrast material using 64-section CT scanner, com-
paring the results with those obtained during late ar-
terial or pancreatic parenchymal phase (PPP) of the 
standard multiphase MDCT. 
MaTeRIal and MeThodS
patients
For this retrospective study the institutional review 
board approval was obtained. We retrospectively re-
viewed follow-up thoracic, and abdominal SB 64-slice 
CTs (Philips Healthcare, Best, The Netherlands) of 37 
patients (female: 18, male: 9; mean age, 66.1±14.2 
years; range 17-80 years) with normal pancreas per-
formed at our institution between February 2012 
Figure 1. Schematic view of split-bolus 64-detector row cT scanning of the chest and abdomen in a 75 Kg patient. First bolus [at the start 
of bolus injection (or time zero)]: 90 ml of contrast medium at 2.0 ml/sec, followed by 20 ml of saline solution at same flow rate, is in-
jected to obtain adequate abdominal parenchymal and venous system enhancement; second bolus: 60 ml of contrast medium at 3.50 
ml/s followed by 20 ml of saline solution at the same flow rate to obtain hepatic arterial phase.  We used bolus tracking set (raising the 
threshold value at 500 Hu) with a circular region-of- interest (roi) placed in the descending aorta. approximately at the end of the second 
bolus injection of contrast medium, the scan started cranio-caudally after a delay of at least 6 sec from the arrival of the contrast medium 
in the aorta. using the scout film, a scan range from the pulmonary apex to the pubic symphysis was determined.  a single acquisition 
from the pulmonary apex to the pubic symphysis was performed, resulting in a simultaneous contrast enhancement of the arterial and 
venous system.
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and July 2014. These patients had undergone tripha-
sic MDCT scanning for primary non-malignant panc-
reatic tumors between January 2011 and April 2013. 
No patient had history of pancreatic or liver disease 
or marked atrophy of the pancreatic parenchyma. 
SB-MDCT protocol provided unenhanced scans of 
the upper abdomen and acquisition of the chest-
abdomen-pelvis in a single-pass after intravenous in-
jection of contrast material (Iopamidolo, Iopamiro® 
370 mgI/mL; Bracco, Milano, Italy and Iopromide, 
Ultravist® 370 mgI/mL Schering AG, Berlin, Germany), 
splitted into two boluses (Figure 1) by a power injec-
tor (Stelland CT; Medrad, Indianola, Pennsylvania).
In the SB-MDCT protocol, by applying simultaneous 
injections of two contrast material boli, provided a 
late arterial (or PPP) and a PVP, in a single-pass. 
Volume of the contrast material was calculated as 2 
mL/Kg, with a maximum dose of 150 mL. A schematic 
representation of SB-MDC single pass in a 75 Kg pati-
ent is shown in Figure 1.
Flow rate of the contrast material, duration of injecti-
on and injection times were established according to 
the literature data24,26-28, and broad clinical experien-
ce. Hepatic enhancement during PVP occured about 
80-85 seconds after the start of intravenous injection 
of a bolus of contrast material and the PPP occured 
about 35 seconds after the start of intravenous injec-
tion of a bolus of contrast material.
Thus, with the first dose of 90 mL of contrast materi-
al, 20 mL of saline were delivered at a flow rate of 2 
mL/sec within 55 seconds; the second dose of 60 mL 
of contrast material and 20 mL of saline was subse-
quently injected, and scanning (from the pulmonary 
apex) was performed 30 seconds after the second 
bolus for PPP or 85 seconds after the first bolus for 
PVP. 
We used manual bolus-tracking technique for the 
start of the scan. Threshold value at 500 Hounsfield 
Units (HU) was raised and a circular region of interest 
(ROI) in the descending aorta was determined. The 
scan was started manually 6 seconds after the arrival 
of the second bolus of contrast material in the aorta, 
and from the pulmonary apex to the pubic symphysis 
was scanned . 
In a single-pass a synchronous optimal hepatic en-
hancement during PVP and PPP was obtained.
For SB-MDCT technique, the following acquisition 
parameters were set: slice thickness 2.5 mm; gantry 
rotation speed 0.75 seconds; pitch 0.935:1; recons-
truction index 1.25; tube voltage 120 kVp; for the 
tube current was used the automatic milliampere 
setting, based on patient’s weight.
MDCT examinations were completed with sagit-
Table 1. mean attenuation values (in Hu) in 37 patients with normal pancreatic parenchyma at split-bolus and on pancreatic parench-
ymal phase of standard mDcT in our experience and in literature. 
Pancreas
Celiac axis
SMA
SMV
Portal vein
Mean value 
122
228
245
171
180
maximum
mean value
165.80
474.81
420.10
269.5
240.22
*Data reported by Mc Nulty et al.9; SMA: superior mesenteric artery; SMV: superior mesenteric vein.  
Minimum
mean value
65.7
205.3
179
119.8
115.6
Mean
value
126
324.3
314.39
180.79
190.48
maximum
mean value
165.80
474.81
420.10
269.5
240.22
Minimum
mean value
65.7
205.3
179
119.8
115.6
Mean
value
126
324.3
314.39
180.79
190.48
mean attenuation values 
on ppp
mean attenuation values on 
split-bolus
Mean 
attenuation 
values on 
ppp*
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tal, coronal and curved multiplanar reconstructions 
(MPR). 
analyses of images 
All CT images were transferred from local digital me-
dia to a viewing station (Advantage Workstation 4.2; 
Magicview Philips, Nederlands) and independently 
reviewed by two radiologists (M.S., A.D.A.) with at 
least 25, and 15 years of experience in interpreting 
body CT images, respectively.
Image quality was rated on the following 5-point 
scale:
1. Excellent (excellent delineation of the pancreas 
and of the surrounding structures); 
2. Good (good pancreas delineation, low backgro-
und noise);
3. Adequate (adequate delineation of the pancreas 
and of surrounding structures, mild background 
noise); 
4. Poor (poor definition of pancreas, low attenuation 
and difficult delineation of the structures, increa-
sed image noise, diagnostic confidence reduced); 
poor delineation of the pancreas and peripancre-
atic structures, considerable background noise); 
5. Very poor, not diagnostic.
The two radiologists also reported all factors influen-
cing quality of images (obesity, metallic and motion 
artifacts, contrast timing and contrast material flow-
related). 
The attenuation values of the pancreas in HU, were 
measured positioning three circular ROIs of equal 
size, in the most homogeneous regions of the head, 
the body and the tail of the pancreas, respectively, 
and then the mean attenuation in HU was calcula-
ted.
Mean attenuation values of the SB-MDCT were com-
pared with the values of the PPP obtained in our ex-
perience and reported in the literature9,25. 
The statistical significance of the comparison was as-
sessed by Student’s t test. P value <0.05 was conside-
red statistically significant.
Dose radiation analysis 
The dosimetric evaluation was performed analyzing 
the MDCT examinations with SB protocol in the pati-
ents enrolled in the study. Radiation dose measure-
ment was based on volume CT dose index (CTDIvol) 
and dose-length-product (DLP). The effective dose 
(ED; Sievert, Sv) was calculated using the following 
equation: 
ED= k x DLP k= 0.015 (conversion coefficient)30. 
ReSulTS
SB- MDCT technique provided imaging of high qua-
lity in all cases. 
Mean attenuation values in HU, concentration and 
volume of contrast material in 37 patients with nor-
mal pancreatic parenchyma who underwent SB-
MDCT and those obtained on PPP in our experience 
and in the literature are shown in Table 1. 
The mean enhancement value of normal pancreatic 
parenchyma (mean values in the head, body, and 
tail) by SB-MDCT was 131.35 HU±20.63 (ranged from 
84.15 to 187.3 HU), and it was higher than that of 
the mean enhancement value on PPP of standard 
multiphase MDCT technique reported in the literatu-
re (122 HU) and in our experience (126.1 HU±20.01, 
ranged from 65.7 to 165.80 HU). Difference between 
the mean attenuation values of SB-MDCT and PPP of 
standard MDCT technique in our experience was not 
statistically significant (P=0.27). These values were 
higher comparing with those reported on PPP in the 
literature (average 122 HU)9.
Maximal enhancement of the celiac axis observed on 
SB-MDCT and on PPP of standard triphasic MDCT in 
our experience (456.9 HU vs 474.81 HU) was subs-
tantially similar, and statistically significant differen-
ce was not detected between the mean attenuation 
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values of celiac axis at SB-MDCT and those of the 
standard multiphase protocol at PPP (310.6 HU vs 
324.3 HU respectively; P=0.34). 
Maximal enhancement of superior mesenteric artery 
observed during SB-MDCT and PPP of standard MDCT 
was 420 HU vs 420.1 HU respectively; any statistically 
significant difference was not observed between the 
mean attenuation values at SB-MDCT and those of 
the standard multiphase protocol at PPP (298.77 HU 
vs 314.39 HU respectively; P=0.27).
Maximal enhancement of the superior mesenteric 
vein and portal vein was observed during the SB-
MDCT. A statistically significant difference was not 
observed between the mean attenuation values of 
superior mesenteric vein at SB-MDCT and those of 
the standard multiphase protocol at PVP (195.85 HU 
vs 180.79 HU respectively; P =0.06).
The attenuation values of the main portal vein at 
SB-MDCT were significantly higher than those of the 
standard multiphase protocol at PVP (215.03 HU vs 
190.48 HU, respectively; P=0.001).
A representative  case of pancreas with normal cont-
rast enhancement at SB-MDCT is shown in Figure 2.
In our 37 patients, whole-body SB-MDCT in a single-
pass provided a radiation dose in mSv ranged from 
12.14 to 27.01 mSv (average 19.3±6.3 mSv) with a 
reduction of approximately 17% with respect to stan-
Figure 2. 60-year-old man with normal pancreas. Pancreatic parenchymal phase during triphasic (a,b) mDcT and combined arterial-venous 
phase of the split-bolus (c,d) mDcT technique.  Pancreatic parenchymal phase (a,b) shows pancreatic parenchyma (*) which is 114.6 Hu 
compared  with 141.2 Hu of combined arterial-venous phase of the split-bolus (c,d). on combined arterial and venous phase of split bolus 
(c,d) mDcT, there is also greater enhancement of the superior mesenteric artery (arrow head in c,d) and mesenteric vein (arrow in c) and 
portal vein (thin arrow in d).
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dard triphasic MDCT in our experience. A potentially 
dose reduction can be obtained when compared 
with an unenhanced acquisition, and SB of the upper 
abdomen. Our results were lower than those repor-
ted in the literature25.
dISCuSSIoN
MCDT is the procedure of choice in the identifica-
tion of pancreatic malignancy6 and other unusual 
tumors7,8. CT, in particular, is the method of choice 
in the assessment of normal pancreatic parench-
yma and in the detection and staging of pancreatic 
adenocarcinoma9,12,20. The majority of standard CT 
protocols9,11,12,31-34, entails an unenhanced acquisiti-
on followed by pancreatic parenchymal phase (PPP), 
portal venous phase (PVP) and delayed phase.
This combination of contrast phases, although per-
formed with different CT scanners, flow rates and vo-
lumes of contrast material, provides perfect conspi-
cuity of pancreatic tumor, its proximity to vessels and 
detection of metastases. PPP during the standard bi-
or triphasic CT, is the most sensitive phase for the 
evaluation of pancreatic parenchyma9,20. An average 
volume of 135 mL of contrast material delivered at a 
flow rate of 4 mL/sec, provides a pancreatic enhan-
cement ranging from 82.2 HU to 122 HU (average 
105.7 HU)9. 
Nevertheless, multiphase CT also exposes the pati-
ent to very high radiation doses.
Recently, to reduce the radiation exposure and to 
maintain diagnostic value of CT and its image quality, 
split-bolus (SB) contrast injection with spectral MDCT 
imaging of the normal pancreas and pancreatic ade-
nocarcinoma has been proposed25. 
 
As radiologists we need to reduce the radiation ex-
posure, due to its known risks, without deterioration 
of the image quality and, most importantly, mainta-
ining diagnostic efficacy of the CT scan. Among CT 
protocols for pancreas evaluation, the aim is to ob-
tain an optimal pancreatic enhancement to identify 
normal pancreatic parenchyma and to maximize the 
attenuation difference between the tumor and the 
surrounding pancreatic parenchyma.
In addition, assessment of peripancreatic vessels, 
lymph nodes and detection and characterization of 
focal liver lesion are needed. 
Our aim is to evaluate the feasibility of SB 64-
multidetector row CT compared to PPP of the stan-
dard MDCT scan protocol in the evaluation of the en-
hancement of the normal pancreatic parenchyma.
In the study of Brook et al.25, using CT unit with spect-
ral imaging, SB spectral CT was combined with panc-
reatic and portal venous phases in a single scan thro-
ugh two contrast material injections separated by a 
short pause: 70 seconds before CT, 100 mL of cont-
rast materials were injected for the PVP, followed by 
a second injection of 40 mL of contrast material app-
roximately 35 seconds later, to boost the pancreatic 
phase. Using the bolus-tracking technique scanning 
started 15 seconds after aorta attenuation reached 
280 HU. Mean values of enhancement of normal 
pancreatic parenchyma for SB and standard protocol 
in PPP were 212.2 HU±64.7 vs 105.1 HU±29.3 res-
pectively and the mean effective dose by SB was 20 
mSv25.
 
Our results, with respect to the normal pancreatic en-
hancement, differ from those of Brook because our 
study included patients of different ages and weights. 
Besides, we did not use CT unit with spectral imaging 
and, finally, injections of two contrast materials were 
not separated by a short pause and flow rate and vo-
lume of contrast materials were different.
These results have encouraged the use of SB-MDCT 
technique in the evaluation of the pancreas becau-
se this improvement in enhancement can enable a 
greater conspicuity and visualization of the pancre-
atic neoplasm and other pancreatic abnormalities. 
SB-MDCT also provides an accurate evaluation of the 
peripancreatic arterial and venous vessels and lymph 
nodes, that is essential to stage pancreatic cancer. In 
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addition synchronous phases (arterial and parench-
ymal hepatic enhancement during PVP) provide an 
optimal evaluation of both pancreas and liver (ie de-
tection of hypervascular and hypovascular metasta-
ses). A further advantage of the SB-MDCT protocol is 
reduction of the effective dose of radiation compa-
red to bi- or triphasic MDCT technique.
A potential reduction of radiation dose down to 60% 
should be obtained if the SB-MDCT protocol was 
used in the study of the upper abdomen. This is im-
portant for example in the follow-up of the patients 
with necrotizing pancreatitis, in whom it is necessary 
to rescan them 7-10 days later, to evaluate size, ex-
tension and characteristics of the postnecrotic fluid 
collections.
Study limitation: our study included a small number 
of patients with different ages and body weights wit-
hout pancreatic abnormalities, who had undergone 
whole body CT in the follow-up for malignant tumor. 
In conclusion, these preliminary results demonstra-
ted the effectiveness of SB 64-section MDCT scanner 
in the evaluation of the pancreas. The advantages of 
SB-MDCT protocol in the study of the pancreas are 
its ability to provide an optimal enhancement of the 
normal pancreatic parenchyma that allows detection 
of the tumor, in addition to the possibility to minimi-
ze radiation dose and number of images and data to 
be stored.
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